A BiO‐Optimizing Site Targeted (BOOST) Approach to Periodontal Regeneration Through Local Doxycycline Prior to Surgery: A Randomized Clinical Trial
Journal of Periodontal Research · 2026
DOI: 10.1111/jre.13389 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Periodontal Research, 2026. Verfasst von Mario Aimetti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, C.I.R. Dental School, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Doxycycline, Anti-Bacterial Agents, Guided Tissue Regeneration, Periodontal, Periodontitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kulzer GmbH, Hanau, Germany.
Abstract (Originalsprache)
Aim
To test a BiO‐Optimizing Site Targeted (BOOST) approach to periodontal regeneration by the adjunctive use of locally delivered doxycycline (DOX) 2 weeks prior to minimally invasive surgery in terms of clinical and radiographic outcomes at 1 year.
Methods
For this randomized clinical trial, stage III/IV periodontitis patients presenting sites with intrabony defects and bleeding on probing (BoP+) after steps 1–2 of periodontal treatment were included. Sites were treated via subgingival instrumentation with or without a BOOST approach by local DOX. After 2 weeks, defects were accessed by minimally invasive surgical technique with xenograft and amelogenins. Primary (clinical attachment level [CAL] gain) and secondary (probing pocket depth [PPD] reduction, composite outcomes, radiographic bone defect fill) outcomes were assessed at 12 months.
Results
Sixty patients completed the study (30 on each group). BOOST led to lower preoperative BoP ( p < 0.001) and better wound healing after surgery ( p = 0.027). Both groups showed clinical and radiographic improvements at 1 year, with significant differences in mean CAL gain (4.1 ± 1.9 vs. 3.2 ± 2.0 mm; p = 0.019) and PPD reduction (4.4 ± 1.8 vs. 3.6 ± 1.9 mm; p = 0.040) favoring the test group. BOOST group also achieved higher composite outcome measure (PPD ≤ 4 mm and CAL gain ≥ 3; 83.3% vs. 46.7%; p = 0.006), pocket closure (PPD ≤ 3 mm or 4 mm BoP−; 83.3% vs. 60.0%; p = 0.045), and defect fill (3.5 ± 1.2 vs. 2.7 ± 1.3 mm; p < 0.001) compared to the control group.
Conclusion
A BOOST approach by local doxycycline 2 weeks before surgery enhanced the local inflammatory control prior to periodontal regeneration and post‐operative early wound healing, yielding to improved clinical and radiographic outcomes at 1 year. Trial Registration ClinicalTrials.gov identifier: NCT05878353
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences, C.I.R. Dental School, University of Turin, Turin, Italy.
ORCID-Profile: Mario Aimetti, Giacomo Baima, Federica Romano
Förderung
- Kulzer GmbH, Hanau, Germany
Zitieren
APA
Aimetti, M., Baima, G., Lorenzetti, V., Aliyeva, N., Bottone, M., Mariani, G. M., & Romano, F. (2026). A BiO‐Optimizing Site Targeted (BOOST) Approach to Periodontal Regeneration Through Local Doxycycline Prior to Surgery: A Randomized Clinical Trial. Journal of Periodontal Research. https://doi.org/10.1111/jre.13389
Vancouver
Aimetti M, Baima G, Lorenzetti V, Aliyeva N, Bottone M, Mariani GM, et al. A BiO‐Optimizing Site Targeted (BOOST) Approach to Periodontal Regeneration Through Local Doxycycline Prior to Surgery: A Randomized Clinical Trial. Journal of Periodontal Research. 2026. doi:10.1111/jre.13389
BibTeX
@article{Aimetti2026,
author = {Aimetti, Mario and Baima, Giacomo and Lorenzetti, Virginia and Aliyeva, Nargiz and Bottone, Mario and Mariani, Giulia Maria and Romano, Federica},
title = {A BiO‐Optimizing Site Targeted (BOOST) Approach to Periodontal Regeneration Through Local Doxycycline Prior to Surgery: A Randomized Clinical Trial},
journal = {Journal of Periodontal Research},
year = {2026},
doi = {10.1111/jre.13389}
}
EUVIMED